THIS CONTENT IS FOR SCIENTIFIC AND EDUCATIONAL PURPOSES - NOT FOR SALES OR PROMOTIONAL USAGE
Geneva, the universal gynecological applicator
Designed for up to stage IIB cervical cancer, Geneva is ideal for treating up to 75 percent of patients with locally advanced disease. This first webinar in the series will cover applicator components and how to assemble the product, treatment planning, and optimization per EMBRACE II and QA.